The Department of Justice (DOJ) is seeking to appeal a federal judge’s decision on the CDC’s travel mask warrant; FDA Issues Warning About Harmful Drug Ingredients In Dietary Supplements; Florida Department of Health releases advice on transgender care for young people.
DOJ appeals travel mask mandate decision
In response to the CDC’s ruling that mask-wearing remains necessary to ensure public health, the Department of Justice (DOJ) said it is appealing a federal judge’s ruling that overturned a nationwide mask mandate for public transport. In making her decision, U.S. District Judge Kathryn Kimball Mizelle claimed the CDC exceeded its authority and failed to properly follow the rulemaking process. As reported by NPR, the Biden administration previously said it would appeal after checking with the CDC, which then asked the DOJ to intervene. The appeal was issued 2 days after the mask mandate was canceled
FDA issues warning for dietary supplements
According to Reuters, the FDA has warned against buying certain dietary supplements sold with variations of “Artiri” or “Ortiga” in the name because they may contain potentially harmful ingredients that are not listed on their nutrition labels. The agency said lab tests found some products contained varying amounts of dexamethasone, which is a muscle relaxant. The products, often sold online and in retail stores, have been marketed to treat arthritis, muscle pain and other conditions. The specific products in which the drug has been detected are Artri Ajo King, Artri King, Ortiga Mas Ajo Rey and Ortiga Mas Ajo Rey Extra Forte.
Florida releases guidelines for transgender care
According to a report by ABC News. The agency disagreed with HHS’s approach of supporting and protecting transgender youth, their families, caregivers and teachers, suggesting the HHS decision was intended to impose a political ideology on healthcare children. The news comes after HHS released its guidelines stating that gender-affirming care for transgender minors, when medically necessary, can lead to improvements in their physical and mental health. The Florida DOH said social gender transition, including puberty blockers and hormone therapy, should not be an option for people under 18.
